Johnson & Johnson Earnings Beat Boosted by Hepatitis Drug - Presented by: The Aol. On Network

Shares of Johnson & Johnson are in focus on Tuesday after the company posted second quarter results which were better than what Wall Street was expecting. Johnson & Johnson says sales around the world were strong. Excluding one time charges, J&J earned $1.66 a share, that's more than 10 cents better than expectations. Revenue for the quarter was $19.5 billion, slightly better than expectations and a 9 percent increase compared to the same period a year ago.



Related Videos

Most Popular Videos

Latest Videos